Info@ThinkPinkRocks.org

Galmed Pharmaceuticals Ltd. (“Galmed”) today announced the pricing of its initial public offering of 2,837,400 ordinary shares at a public offering price of $13.50 per share, before underwriting discounts and commissions.

Read More:
Galmed Pharmaceuticals prices initial public offering of 2,837,400 shares

Scroll to Top